Vitazka, Patrik
Bristol-Myers Squibb (United States)
2 papers on CoChat
Most cited papers
- Verified
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
Skoulidis, F., Goldberg, M. E., Greenawalt, D. M., Hellmann, M. D., Awad, M. M., Gainor, J. F., Schrock, A. B., Hartmaier, R. J., Trabucco, S. E., Gay, L., et al. (2018) · Cancer Discovery
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 1,641
- Verified
Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer
Hellmann, M. D., Nathanson, T., Rizvi, H., Creelan, B. C., Sanchez-Vega, F., Ahuja, A., Ni, A., Novik, J. B., Mangarin, L. M. B., Abu-Akeel, M., et al. (2018) · Cancer Cell
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 1,095
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free